Rising Demand for Probiotic Supplements in Pediatric Nutrition to Drive Infant, Child, and Maternal Probiotic Supplements Market
According to our latest market study, titled “Infant, Child, and Maternal Probiotic Supplements Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by From (Capsules and Softgels, Gummies, Liquid, Others), End-User (Infant and Toddler, Children, and Maternal Women),’’ the market is projected to reach US$ 1,081.70 million by 2028 from US$ 604.94 million in 2021. It is expected to grow at a CAGR of 8.7% from 2022 to 2028.
Of late, parents have become more concerned about specific nutrition for their children to ensure proper growth and development. According to the World Health Organization (WHO), providing proper nutrition to babies in their first 3 years can reduce mortality and morbidity in them, decrease the risk of chronic diseases throughout their lifetime, and promote regular mental and physical growth. The poor nutrition of infants can cause serious health issues, including stunted growth and malnutrition.
Additionally, poor nutrition during the first 3 months of a baby's life can increase the risk of death. However, the rise in awareness regarding proper infant nutrition among parents has reduced the infant mortality rate. According to the Center for Disease Control and Prevention (CDC), the infant mortality rate in the US in 2020 was 5.4 deaths per 1,000 live births.
Due to their underlying benefits, infant and child probiotic supplements have also gained immense traction among parents. Probiotics help relieve acute constipation, acid reflux, and colic in healthy infants and children. It also helps build a strong barrier against distress, causing bacteria in the gastrointestinal (GI) tract of infants and children, improving their immunity and digestive health.
Key players operating in the global infant, child, and maternal probiotic supplements market include Bayer Corporation; Nestle S.A.; Mommy’s Bliss Inc.; LoveBug Probiotics; BioGaia AB; MaryRuth Organics, LLC; Pharmavite LLC; Evolve Biosystems; Biomeology; and Nordic Naturals. These companies have a widespread global presence, which allows them to serve a large set of customers from all over the world and subsequently increases their market share. They are actively focusing on new products launch and geographical expansion to expand their product range in specialty portfolios.
Impact of COVID-19 Pandemic on Infant, Child, and Maternal Probiotic Supplements Market
During the initial phase of the COVID-19 pandemic, the implementation of lockdown restrictions and shutdown of manufacturing units led to a production shortfall, which created a demand and supply gap. These factors hampered the profitability of various small-scale and large-scale manufacturers of infant, child, and maternal probiotic supplements. However, due to increased health consciousness among people, the demand for various supplements, such as multivitamins, vitamin %, omega 3, and probiotic supplements, increased significantly. Clinical evidence shows that probiotic supplements help combat viral infections, including COVID-19, by boosting immunity. There is a critical relationship between the gut microbiome and systemic immune reactions, including those at distant mucosal sites, such as the lungs.
E-commerce played a crucial role during the initial months of the pandemic as people were mandated to stay at home and many brick-and-mortar stores were shut. E-pharmacies and online drugstores witnessed tremendous demand for medicines and supplements as they offered home delivery services even during lockdowns. The online sales of nutraceuticals and medicines, including probiotic supplements for infants, children, and pregnant women, increased steadily during the pandemic. Consumers are expected to continue with the online shopping trend even in the near future. This factor is expected to offer attractive opportunities to the infant, child, and maternal probiotic supplements market in the coming years.
Infant, Child, and Maternal Probiotic Supplements Market Breakdown – by Region
Infant, Child, and Maternal Probiotic Supplements Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Form (Capsules and Softgels, Gummies, Liquid, and Others) and End User (Infant and Toddler, Children, and Maternal Women)
Infant, Child, and Maternal Probiotic Supplements Market to 2028
Download Free Sample
The report segments the Infant, Child, and Maternal Probiotic Supplements Market as follows:
Based on product type, the infant, child, and maternal probiotic supplements market is segmented into capsules and soft gels, gummies, liquid, and others. Based on end user, the market is segmented into infants and toddlers, children, and maternal women. Based on geography, the market is segmented into North America, Europe, Asia Pacific (APAC), and the Rest of the World (RoW).